hotspot -WSS

hotspot

author：leisure time 2025-10-02 15:44:17 - browse：3321

Adam's take main illustration — Molly Ferguson/STAT

Hello! Some takes and thoughts on Gilead’s Trodelvy troubles, Elevation Oncology’s surprising rise, and Kura Oncology’s “wall-crossing” stock sale.

Gilead needs Arcellx more than ever

The clinical trial setback for Trodelvy in non-small cell lung cancer reported by Gilead Sciences on Monday was another dose of bad news for the company’s oncology business. Strategically, does it make sense for Gilead to invest even more in antibody-drug conjugates like Trodelvy, where its lackluster profile and increased competition overall makes winning seem unlikely? Or, should Gilead double down on its Kite division and CAR-T cell therapy — the type of cancer treatments where it truly excels?

If the answers to those questions are no and yes (I lean that way), then Gilead’s current partnership with Arcellx, which is developing a BCMA-targeted CAR-T therapy for multiple myeloma, becomes a lot more important.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： HHS's proposed rule does nothing to address the climate crisis

Wikipedia

WSS

Empower primary care with adequate payments and technology

HHS's proposed rule does nothing to address the climate crisis

PBM executives asked to testify by House panel

For Medicare Advantage, Democrats want stronger protections around AI

Crowdfunding for medical bills sidesteps core problem, author says

PBM executives asked to testify by House panel

explore

hotspot

Gilead needs Arcellx more than ever

knowledge

Supreme Court strikes down use of affirmative action

Key House Republican on health care plans exit from Congress

Supreme Court strikes down use of affirmative action

Novel spinal cord stimulator treats paralysis without surgery

In Memoriam: Notable people who died in 2023

Readout LOUD podcast: How biotech is using artificial intelligence

Continuity nursing helped my family in our darkest PICU moments

The effects of a landmark ruling on DNA ownership are becoming clearer

Medicare details structure of new drug price negotiation program

Crowdfunding for medical bills sidesteps core problem, author says

knowledge

Robert F. Kennedy is pitching centrism on health, even on abortion

The effects of a landmark ruling on DNA ownership are becoming clearer

Has Bernie Sanders reached the limit of his pharma bullying effort?

Class action alleges UnitedHealth concealed DOJ probe

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

PBM executives asked to testify by House panel

entertainment

leisure time

Wikipedia

Wikipedia